NEUCA S.A. (WSE:NEU)
700.00
-3.00 (-0.43%)
Jun 2, 2025, 3:45 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Wholesale Distribution of Medicines | 10.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Wholesale Distribution of Medicines Growth | 2.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinical Trials | 402.53M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinical Trials Growth | 107.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Operator | 271.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medical Operator Growth | 37.92% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Insurance Activities | 134.93M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Insurance Activities Growth | 28.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufacturer of Pharmaceuticals | 100.42M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Manufacturer of Pharmaceuticals Growth | 74.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinics, Clinical Trials, and Telemedicine | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Clinics, Clinical Trials, and Telemedicine Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Poland | 11.81B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Poland Growth | 5.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|